Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Advanced Gastric Cancer
NCT01956149Phase 2Completed
- Sponsor
- Institut für Klinische Krebsforschung
- Start
- Sep 2013
- Primary completion
- Dec 2017
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel in gastric cancer (GC), esophagogastric junction cancer, sponsored by Institut für Klinische Krebsforschung. Started Sep 2013; status: completed.
02
Drugs
cabazitaxel
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on NCT01956149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956149.